"Please Note: Due to the COVID-19 virus some locations have moved. Please contact your doctor's office to confirm the address. BMC is restricting all visitors unless pre-approved by each patient's care team under extenuating circumstances. Cancer Treatment Center"

During the past decade, Cancer Research Center at Boston Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 8 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Research Center at Boston Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 25 trials, followed by "Radiation Therapy Oncology Group" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "Boston Medical Center" with 5 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Research Center at Boston Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 46 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Research Center at Boston Medical Center" are "Breast Cancer" (11 trials), "Head and Neck Cancer" (6 trials), "Lung Cancer" (6 trials), "Leukemia" (4 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "Cancer Research Center at Boston Medical Center" in a lesser frequency.

Most popular intervention types in "Cancer Research Center at Boston Medical Center" are "Drug" (44 trials), "Procedure" (17 trials), "Radiation" (16 trials), "Biological" (11 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (12 trials), "cisplatin" (9 trials), "paclitaxel" (9 trials), "carboplatin" (5 trials) and "docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Research Center at Boston Medical Center" are 35 trials for "All" genders, 13 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Research Center at Boston Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Cancer Research Center at Boston Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Research Center at Boston Medical Center, 3 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".